NVP-BKM120
-
Catalog number2619-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name(5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine; BKM-120; Buparlisib
-
DescriptionNVP-BKM120 is a potent inhibitor of class I PI3K isoforms; potently blocks both p110α (IC₅₀ = 52 nM) and p110β (IC₅₀ = 166 nM) in vitro. It is much less effective against the class III PI3K Vps34 and mammalian target of rapamycin (mTOR) and has no effect on PI4Kβ and several other kinases. NVP-BKM120 prevents the growth of assorted cancer cell lines when used at 5 μM and inhibits tumor growth in vivo.
-
CAS Number944396-07-0
-
Structure AvailableY
-
Salt FormNo
-
Molecular FormulaC₁₈H₂₁F₃N₆O₂
-
Molecular Weight410.39
-
Cell PermeableYes
-
Purity>95% by HPLC
-
SolubilitiesDMSO (~15 mg/ml) or EtOH (~15 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA potent PI3K inhibitor
-
Storage Condition-20 ̊C
-
Shipping ConditionGel pack
-
Shelf Life36 months
-
PubChem CID16654980
-
SMILESC1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4
-
InChiInChI=1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23)
-
InChi KeyCWHUFRVAEUJCEF-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameNVP-BKM120
-
Alternative nameNVP-BKM120
-